Association between RASSF1A promoter hypermethylation and oncogenic HPV infection status in invasive cervical cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 14, 2015, Pages 5749-5754

  Li, Jin Yun ^a,b   Huang, Tao ^a,b   Zhang, Cheng ^a   Jiang, Dan Jie ^a   Hong, Qing Xiao ^a   Ji, Hui Hui ^a   Ye, Meng ^b   Duan, Shi Wei ^a  

^a Ningbo Addiction Research and Treatment Center   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

Cervical cancer; HPV infection; Human papilloma virus; Meta analysis; RASSF1A methylation

Indexed keywords

RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COMPLICATION; DNA METHYLATION; FEMALE; GENETICS; HUMAN; META ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; TUMOR INVASION; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84944242444     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.14.5749     Document Type: Article

References (24)

1. Agathanggelou A, Cooper WN, Latif F (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res, 65, 3497-508.
2. Bird AP (1986). CpG-rich islands and the function of DNA methylation. Nature, 321, 209-13.
3. Bosch FX, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
4. Brown TC, Juhlin CC, Healy JM, et al (2014). Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis. JAMA Surg.
5. Castellsagué X (2008). Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol, 110, 4-7.
6. Cheung TH, Lo KW, Yim SF, et al (2004). Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol, 93, 621-7.
7. Cohen Y, Singer G, Lavie O, et al (2003). The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res, 9, 2981-4.
8. Farthing AJ, Vousden KH (1994). Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol, 2, 170-4.
9. Feng L, Li J, Yan LD, et al (2014). RASSF1A suppresses proliferation of cervical cancer cells. Asian Pac J Cancer Prev, 15, 5917-20.
10. Jha AK, Nikbakht M, Jain V, et al (2012). p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients. Oncol Lett, 3, 1331-5.
11. Jiang D, Hong Q, Shen Y, et al (2014a). The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis. PLoS One, 9, 96822.
12. Jiang D, Shen Y, Dai D, et al (2014b). Meta-analyses of methylation markers for prostate cancer. Tumour Biol.
13. Kuzmin I, Liu L, Dammann R, et al (2003). Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res, 63, 1888-93.
14. Lai HC, Lin YW, Chang CC, et al (2007). Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol, 104, 629-35.
15. Lipsey MW, Wilson DB 2001. Practical meta-analysis, Thousand Oaks, Calif., Sage Publications.
16. Maliukova AV, Loginov VI, Khodyrev DS, et al (2004). (Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors). Mol Biol (Mosk), 38, 1005-13.
17. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
18. Richter AM, Pfeifer GP, Dammann RH (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta, 1796, 114-28.
19. Scheffner M, Werness BA, Huibregtse JM, et al (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-36.
20. Shivakumar L, Minna J, Sakamaki T, et al (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol, 22, 4309-18.
21. van der Weyden L, Adams DJ (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta, 1776, 58-85.
22. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
23. Yu MY, Tong JH, Chan PK, et al (2003). Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer, 105, 204-9.
24. Zhu X, He F, Zeng H, et al (2014). Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet, 46, 287-93.